Ratings Trulieve Cannabis Corp. OTC Markets

Equities

TCNNF

CA89788C1041

Market Closed - OTC Markets Other stock markets 01:29:49 04/05/2024 am IST			5-day change	1st Jan Change
12.4 ^USD	+1.17%		+17.31%	+138.00%

30/04	Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug	RE
23/04	Trulieve Cannabis Corp. Announces Giannella Alvarez Not Stand for Reelection as Director	CI

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company has insufficient levels of profitability.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Pharmaceuticals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TRULIEVE CANNABIS CORP.	+138.00%	2.28B		-
CURALEAF HOLDINGS, INC.	+39.75%	4.18B		C-
GOODNESS GROWTH HOLDINGS, INC.	+138.10%	67.89M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes